CAMBRIDGE, MA, Passkey Therapeutics, the pioneer of Synergistic Multifunctional Therapeutics (SMThs), announced that it has emerged from stealth with $20 million in seed funding.
Passkey Therapeutics, the pioneer of Synergistic Multifunctional Therapeutics (SMThs), announced that it has emerged from stealth with $20 million in seed funding led by Breakout Ventures along with founding investors Innovation Endeavors and Bison Ventures. Additional participants include Wireframe Ventures, Alexandria Venture Investments, and GRIDS Capital.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
